Quote · The Prof G Pod with Scott Galloway
Prof G Markets: Google’s Quantum Breakthrough & The World Cup Goes to Saudi Arabia
Where this was said
GLP-1 Drugs vs. the Alcohol Industry
At 24:32 · chapter starts 16:36
The GLP-1 segment is where the episode finds its sharpest edge. Ed introduces the Eli Lilly news with a new vocabulary term from the CEO: 'anti-hedonics' — drugs that reduce the brain's desire cycle. Scott's framing is more visceral: these drugs are 'scaffolding on our instincts,' updating human biology for a world of industrial-scale food and alcohol production. The numbers are alarming for the drinks sector: Loyola University peer-reviewed research shows a 40% lower opioid overdose rate and 50% lower alcohol intoxication rate for GLP-1 users. Ed catalogs the carnage already underway — Boston Beer down 9%, AB InBev down 15%, Brown-Forman down 20% in a year. Scott delivers the most important insight: the alcohol industry is not built on social drinkers — it's built on the 1% of people who drink 27 beers a day. Those are exactly the people who will get GLP-1 prescriptions first, from doctors telling them they'll die if they keep drinking. When you remove those alcoholic customers, the industry's revenue drops 20-30%, which 'spells restructuring, massive layoffs, a meltdown.' Ed adds the J.M. Smucker CEO's tone-deaf earnings call response — 'snacking continues' — as darkly comic proof of how deep the denial runs. Scott closes the loop: young people have already abandoned alcohol in favor of edibles and other substances, making the drinks industry a slow-motion version of the cable TV collapse. [1] — Scott Galloway "The top 1% of drinkers account for 30-40% of all alcohol consumed — and those heavy drinkers are first in line for GLP-1 prescriptions. If …" 18:46 [2] — Scott Galloway "Top 1% of drinkers = 30-40% of all alcohol consumed: Scott Galloway noted that roughly 1% of alcohol drinkers are responsible for 30-40% of…" 18:46
Scott Galloway cited data showing people on Ozempic reduced their drinking by 60%, signaling a major threat to the alcohol industry.
A Loyola University study found people with opioid or alcohol use disorder who take GLP-1 drugs have a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication.
Over the past year, Boston Beer fell 9%, AB InBev fell 15%, and Brown-Forman fell 20% as the alcohol industry faces the GLP-1 threat.
Scott Galloway noted that roughly 1% of alcohol drinkers are responsible for 30-40% of all alcohol consumption, making alcoholics the core of the drinks industry's business model.
The top 1% of drinkers account for 30-40% of all alcohol consumed — and those heavy drinkers are first in line for GLP-1 prescriptions. If those people quit drinking, the drinks industrial complex faces a 20-30% revenue collapse, mass layoffs, and a restructuring as brutal as cable TV.
At conferences, music festivals, and luxury events, young people are conspicuously absent from bars. They're using edibles, microdosing, and experimenting with substances that don't show up on a bar tab — and the bartender on Scott's cruise ship confirmed it: 'Finally, someone drinking.'
